| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0118b9edad96a84de35db210a6cf3c03 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4519 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-332 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-332 |
| filingDate |
2003-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff69a5e2a5105be645478c5106582939 |
| publicationDate |
2004-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004171954-A1 |
| titleOfInvention |
Methods for determining whether to provide an inhibitor of sympathetic nervous system activity to a human being suffering from an autoimmune disease or fibryomyalgia |
| abstract |
The present invention provides methods for determining whether to provide an inhibitor of sympathetic nervous system activity to a human being suffering from an autoimmune disease and/or fibromyalgia. The methods of this aspect of the invention each include the steps of: (a) measuring the heart rate variability of a human being suffering from an autoimmune disease or fibromyalgia, to yield heart rate variability data; (b) analyzing the heart rate variability data to determine whether there is excessive sympathetic nervous system activity in the heart of the human being; and (c) providing an inhibitor of sympathetic nervous system activity to the human being if there is excessive sympathetic nervous system activity in the heart of the human being. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9642547-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006235320-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545359-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8335559-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8160698-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10058477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7412282-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10406345-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8744573-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9339436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7831299-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8226543-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9693700-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8706214-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007100379-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006025824-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541227-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11172862-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006081340-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006081340-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006122648-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8165671-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006167364-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682067-B2 |
| priorityDate |
2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |